$NVMI

NOVA LTD.

3
0
0

No SEC Form 4 filings for $NVMI in the last 30 days.

Med

Nova’s (NASDAQ:NVMI) Q2 Sales Top Estimates, Inventory Levels Improve

Nova (NASDAQ:NVMI) reported Q2 CY2026 revenue of $255 million, up 15.9% year on year and 1.6% above estimates. Q3 guidance revenue was $282 million at the midpoint, 1.8% above consensus. Non-GAAP EPS was $2.51, 4.1% above estimates. Days inventory outstanding fell to 152, 30 days below its 5-year average.

Nova Reports Strong Revenue Growth In Q2, Announces Q3 Outlook

Nova Ltd. (NVMI) reported Q2 total revenue of $254.9 million versus $219.9 million a year earlier. Net income was $75.0 million, or $2.20 per diluted share, versus $68.3 million, or $2.14. Adjusted net income was $86.5 million, or $2.51. For Q3, it expects revenue of $277 million to $287 million and EPS $2.46 to $2.61 (adjusted $2.70 to $2.85).

Tue: Enlight leads TASE higher

Globes reports the Tel Aviv Stock Exchange rose on Aug. 4, with the Tel Aviv 35 up 0.81% to 4,144.98 and Tel Aviv 125 up 0.45% to 4,050.62. Turnover was NIS 4.65B in equities and NIS 5.04B in bonds. Enlight Renewable Energy (ENLT) gained 7.05% after strong Q2 results; Tower Semiconductor (TSEM) led turnover. Banking and Technology rose; Real Estate fell.

NVMI sentiment & insider activity

Over the past 7 days, alphai's AI scored 3 news stories mentioning NVMI (NOVA LTD.). Coverage has skewed bullish: 3 bullish, 0 neutral, and 0 bearish.

Recent NVMI coverage spans market movers, earnings and geopolitics.

What's driving NVMI

alphai scores every news story that mentions NVMI with an AI model for sentiment and relevance, and aggregates insider trades from NOVA LTD.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $NVMI

Score

Tue: Enlight leads TASE higher

Globes reports the Tel Aviv Stock Exchange rose on Aug. 4, with the Tel Aviv 35 up 0.81% to 4,144.98 and Tel Aviv 125 up 0.45% to 4,050.62. Turnover was NIS 4.65B in equities and NIS 5.04B in bonds. Enlight Renewable Energy (ENLT) gained 7.05% after strong Q2 results; Tower Semiconductor (TSEM) led turnover. Banking and Technology rose; Real Estate fell.

$TEVAMed

Wed: Teva jumps but TASE continues to lose ground

Globes reports the Tel Aviv Stock Exchange fell on July 29, with the Tel Aviv 35 down 0.99% and Tel Aviv 125 down 0.96%. Teva Pharmaceutical (NYSE: TEVA; TASE: TEVA) rose 10.17% after Q2 results and raised revenue guidance. Other movers included Enlight Renewable Energy, Elbit Systems, and banks such as Bank Leumi and Hapoalim.

$TSEMLow

Mon: Chip cos lead sharp falls

Israel stocks fell on Monday. The Tel Aviv 35 Index dropped 2.15% to 4,161.81 and the Tel Aviv 125 Index fell 1.87% to 4,095.62. Chip-related shares led declines: Tower Semiconductor fell 14.56%, Camtek 7.05%, and Nova 7.87%. Nice rose 7.18%. Turnover was NIS 3.98B equities and NIS 5.18B bonds.

$TSEMLow

Tue: Tower leads TASE gains

Israel’s Tel Aviv Stock Exchange rose. Tel Aviv 35 gained 1.39% to 4,193.36 and Tel Aviv 125 rose 1.17% to 4,129.39. Turnover was NIS 4.20B in equities and NIS 7.63B in bonds. Bank Leumi led (+0.80%). Tower Semiconductor jumped 6.44%. Mega Or Holdings fell 5.31% after a halt in permits for new data centers.

$TEVAMed

Mon: Mega Or hit hard by halt in data center permits

Globes reported Tel Aviv markets were mixed on July 20, with the TA-35 down 0.11% and TA-125 flat. Mega Or Holdings (TASE: MGOR) fell 6.04% after Israel’s Electricity Authority halted permits for new data centers. Energy and Communications and Technology indexes rose. Israel Discount Bank (DSCT) led turnover; Elbit Systems (ESLT) rose on a new US contract.

Lam Research and Nova Shares Are Soaring, What You Need To Know

Stocks rose after a cooler-than-expected June core CPI and IBM’s warning that Q2 revenue missed as clients shifted budgets to servers, storage and memory for AI infrastructure. The read-through supported chip names including Lam Research (LRCX, +4.7%) and Nova (NVMI, +4.9%). The article also cites SK Hynix forecast cuts and HBM pricing dynamics.

Related tickers